Favorable response to nivolumab in a young adult patient with metastatic histiocytic sarcoma

Pediatr Blood Cancer. 2019 Jan;66(1):e27491. doi: 10.1002/pbc.27491. Epub 2018 Sep 30.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Antineoplastic Agents, Immunological / therapeutic use*
  • Bone Neoplasms / drug therapy*
  • Bone Neoplasms / immunology
  • Bone Neoplasms / secondary
  • Female
  • Histiocytic Sarcoma / drug therapy*
  • Histiocytic Sarcoma / immunology
  • Histiocytic Sarcoma / pathology
  • Humans
  • Nivolumab / therapeutic use*
  • Prognosis
  • Remission Induction

Substances

  • Antineoplastic Agents, Immunological
  • Nivolumab